Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors
Clinical trial NCT05744427 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05744427
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2026-07-30
- Enrollment
- 725
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.